Rapid and sensitive detection of pathogenic bacteria remains challenging due to insufficient signal gain and uncontrollable signal transduction strategies that are easily perturbed by environmental fluctuations. Here, we present a micro-orifice resistance biosensor that converts a molecular circuit-programmed aggregation-dispersion transition into a quantifiable electrical signal. Entropy-driven circuit acts as the core regulatory module, maintaining signal probes in a stable low-entropy aggregated state while providing a built-in, target-responsive pathway for controlled dispersion. Upon recognition of bacterial DNA, the molecular circuit shifts toward a higher-entropy dissociated state, releasing dispersed microparticles that generate distinct resistance pulse signatures. To enhance initiator availability and strengthen the molecular circuit activation, a hairpin-free bridge-hybridization chain reaction (nHCR) supplies complementary upstream amplification without relying on enzymatic processes. The sensor achieves a limit of detection of 27 CFU/mL for Listeria monocytogenes in an amplification-free manner, comparable to quantitative PCR in real sample analysis. Our molecular circuit-programmed dispersion switching, supported by dual amplification, offers a robust and scalable strategy for rapid pathogen analysis.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: